Skip to content

Drug interactions

Fondaparinux + Zanubrutinib

Severity: Moderate

Fondaparinux and Zanubrutinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Zanubrutinib impairs platelet function and can cause cytopenias, and hemorrhage including serious events is a recognized adverse effect. Combining it with an anticoagulant such as fondaparinux further raises bleeding risk.

What this interaction means in plain words

Fondaparinux and Zanubrutinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Fondaparinux belongs to Cardiovascular; Zanubrutinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive: BTK inhibition impairs platelet signaling and may cause thrombocytopenia, adding to anti-Xa anticoagulation.

What to do

Monitor for bleeding and check blood counts regularly. Assess the benefit and risk of continuing the anticoagulant and consider holding zanubrutinib around surgery.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fondaparinux and Zanubrutinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fondaparinux with Zanubrutinib?

MediHelp rates the interaction as moderate. Fondaparinux and Zanubrutinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Zanubrutinib impairs platelet function and can cause cytopenias, and hemorrhage including serious events is a recognized adverse effect. Combining it with an anticoagulant such as fondaparinux further raises bleeding risk.

How serious is the interaction between Fondaparinux and Zanubrutinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bleeding and check blood counts regularly. Assess the benefit and risk of continuing the anticoagulant and consider holding zanubrutinib around surgery.

What other medicines interact with Fondaparinux?

MediHelp also lists interactions of Fondaparinux with, for example, Defibrotide, Ketorolac, Abciximab. The full list is on the Fondaparinux page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in